Individualizing early use of sirolimus in renal transplantation

Area of Science:

• Nephrology
• Immunology
• Transplantation Medicine

Background:

• Kidney transplant recipients require long-term graft survival.
• Nephrotoxic immunosuppressive agents pose a challenge in post-transplant care.
• Calcineurin inhibitors are standard but can impair renal function.

Purpose of the Study:

• To review the clinical experience and literature on sirolimus use in kidney transplant recipients.
• To evaluate sirolimus as an immunosuppressive agent in the first 12 months post-transplantation.
• To assess the benefits of sirolimus compared to calcineurin inhibitors.

Main Methods:

• Literature review of clinical studies.
• Analysis of clinical experience with sirolimus.
• Comparison of sirolimus-based regimens with calcineurin inhibitor-based regimens.

Main Results:

• Sirolimus is a potent immunosuppressant.
• Sirolimus prevents acute graft rejection.
• Sirolimus improves renal function, histology, and graft survival compared to calcineurin inhibitors.

Conclusions:

• Sirolimus offers a valuable alternative to nephrotoxic immunosuppressants.
• Clinical experience supports the use of sirolimus in kidney transplantation.
• Sirolimus-based immunosuppression can enhance long-term graft survival.